Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab
Sign Up to like & getrecommendations! Published in 2019 at "Investigational New Drugs"
DOI: 10.1007/s10637-019-00770-y
Abstract: SummaryBackground It would be useful to have criteria for predicting long-term treatment responses to immune checkpoint inhibitors (ICIs). Maximum depth of response correlates with treatment outcomes among patients receiving programmed death protein 1 axis inhibitors… read more here.
Keywords: treatment outcomes; early depth; tumor shrinkage; tumor ... See more keywords
Cerebrospinal Fluid Leak in Juvenile Nasopharyngeal Angiofibroma-Rare Sequelae of Flutamide-Induced Tumor Shrinkage.
Sign Up to like & getrecommendations! Published in 2018 at "World neurosurgery"
DOI: 10.1016/j.wneu.2018.07.288
Abstract: BACKGROUND Nonsteroidal androgen receptor blockers like flutamide have been described as an adjuvant treatment for preoperative shrinkage of extensive juvenile nasopharyngeal angiofibroma. We present a case of cerebrospinal fluid (CSF) leak due to flutamide-induced tumor… read more here.
Keywords: tumor; nasopharyngeal angiofibroma; leak; shrinkage ... See more keywords
Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Urology"
DOI: 10.1111/iju.14964
Abstract: To investigate the tumor shrinkage patterns of patients with metastatic renal cell carcinoma treated with nivolumab monotherapy. read more here.
Keywords: cell carcinoma; renal cell; nivolumab monotherapy; tumor shrinkage ... See more keywords
Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Endocrine journal"
DOI: 10.1507/endocrj.ej17-0104
Abstract: Although advanced thyroid carcinoma patients who cannot be cured by conventional therapy have lacked effective treatment, multitargeted tyrosine kinase inhibitors have recently become available. Phase 3 trials of lenvatinib showed a median time to objective… read more here.
Keywords: early tumor; advanced thyroid; thyroid carcinoma; tumor shrinkage ... See more keywords
A Case of Hepatocellular Carcinoma Showing Tumor Shrinkage due to an Abscopal Effect.
Sign Up to like & getrecommendations! Published in 2023 at "Internal medicine"
DOI: 10.2169/internalmedicine.1844-23
Abstract: We herein report a 63-year-old man who presented with left lower jaw pain and was diagnosed with hepatocellular carcinoma with bone metastases post-examination. All tumors grew after immunotherapy with atezolizumab and bevacizumab, and his jaw… read more here.
Keywords: abscopal effect; hepatocellular carcinoma; case; tumor shrinkage ... See more keywords
Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases
Sign Up to like & getrecommendations! Published in 2018 at "AntiCancer Research"
DOI: 10.21873/anticanres.13014
Abstract: Background/Aim: Anti-EGFR antibodies or bevacizumab comprise first-line treatment for patients with RAS wild-type colorectal liver metastases (CLM). Which marker better predicts efficacy, early tumor shrinkage or morphologic response, still remains unclear. Patients and Methods: We… read more here.
Keywords: morphologic response; tumor shrinkage; colorectal liver;
A Pharmacokinetic-Pharmacodynamic Model Predicts Uracil-tegafur Effect on Tumor Shrinkage and Myelosuppression in a Colorectal Cancer Rat Model
Sign Up to like & getrecommendations! Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16257
Abstract: Background/Aim: Oral 5-fluorouracil (5-FU)-based prodrugs, used in cancer chemotherapeutic regimens, exhibit large inter- and intra-patient variability in plasma 5-FU concentrations, contributing to treatment failure. Although dosage determination criteria according to plasma drug concentrations are required,… read more here.
Keywords: tumor shrinkage; uracil tegafur; colorectal cancer; model ... See more keywords
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14143317
Abstract: Simple Summary Neuroendocrine tumors (NETs) are rare disorders of neuroendocrine cells with an increasing incidence. Surgical resection is the only cure; however, they are often found at an advanced stage, and many cases are unresectable… read more here.
Keywords: tumor shrinkage; peptide receptor; neuroendocrine tumors; shrinkage ... See more keywords